Kerang Zhang

8.9k total citations · 2 hit papers
129 papers, 4.3k citations indexed

About

Kerang Zhang is a scholar working on Cognitive Neuroscience, Molecular Biology and Experimental and Cognitive Psychology. According to data from OpenAlex, Kerang Zhang has authored 129 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Cognitive Neuroscience, 29 papers in Molecular Biology and 28 papers in Experimental and Cognitive Psychology. Recurrent topics in Kerang Zhang's work include Functional Brain Connectivity Studies (50 papers), Tryptophan and brain disorders (26 papers) and Treatment of Major Depression (24 papers). Kerang Zhang is often cited by papers focused on Functional Brain Connectivity Studies (50 papers), Tryptophan and brain disorders (26 papers) and Treatment of Major Depression (24 papers). Kerang Zhang collaborates with scholars based in China, United States and United Kingdom. Kerang Zhang's co-authors include Ning Sun, Zhifen Liu, Chunxia Yang, Yong Xu, Ai‐Xia Zhang, Penghong Liu, Lijun Kang, Zhongchun Liu, Zhongxiang Cai and Shaohua Hu and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer.

In The Last Decade

Kerang Zhang

128 papers receiving 4.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact on mental health and perceptions of psychological care among medical and nursing staff in Wuhan during the 2019 novel coronavirus disease outbreak: A cross-sectional study

2020 1.1k citations Kerang Zhang et al. profile →
Immunoregulatory role of the gut microbiota in inflammatory depression

2024 110 citations Penghong Liu, Zhifen Liu et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kerang Zhang China	32	1.2k	1.1k	991	636	609	129	4.3k
Reinhard Heun Germany	51	1.2k 1.0×	1.4k 1.2×	1.4k 1.4×	489 0.8×	684 1.1×	214	8.0k
Hai‐Gwo Hwu Taiwan	43	2.5k 2.1×	1.8k 1.6×	1.1k 1.1×	255 0.4×	964 1.6×	232	7.6k
Richard Bruggeman Netherlands	41	1.4k 1.2×	1.1k 1.0×	552 0.6×	353 0.6×	895 1.5×	243	5.7k
Stefan Bleich Germany	51	1.2k 1.0×	507 0.4×	2.1k 2.2×	291 0.5×	357 0.6×	329	7.8k
David A. Mrazek United States	46	1.5k 1.3×	506 0.4×	1.2k 1.2×	383 0.6×	636 1.0×	145	6.3k
Geert Dom Belgium	40	1.0k 0.9×	769 0.7×	1.1k 1.1×	336 0.5×	531 0.9×	165	4.9k
Byung‐Joo Ham South Korea	41	664 0.6×	1.4k 1.2×	659 0.7×	278 0.4×	596 1.0×	197	4.6k
Toshiyuki Someya Japan	38	1.1k 0.9×	1.1k 1.0×	1.1k 1.1×	152 0.2×	379 0.6×	281	5.9k
Xiaohong Ma China	40	538 0.4×	2.0k 1.7×	865 0.9×	123 0.2×	580 1.0×	262	5.1k
Jerzy Samochowiec Poland	36	870 0.7×	517 0.5×	1.3k 1.3×	237 0.4×	412 0.7×	321	5.4k

Countries citing papers authored by Kerang Zhang

Since Specialization

Citations

This map shows the geographic impact of Kerang Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerang Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerang Zhang more than expected).

Fields of papers citing papers by Kerang Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerang Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerang Zhang. The network helps show where Kerang Zhang may publish in the future.

Co-authorship network of co-authors of Kerang Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Kerang Zhang. A scholar is included among the top collaborators of Kerang Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerang Zhang. Kerang Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Jiao, Zhiliang Long, Gong‐Jun Ji, et al.. (2025). Major depressive disorder on a neuromorphic continuum. Nature Communications. 16(1). 2405–2405. 5 indexed citations

Liu, Penghong, Shasha Liu, Lixin Liu, et al.. (2024). Characteristics of gut microbiota and its correlation with hs-CRP and somatic symptoms in first-episode treatment-naive major depressive disorder. Journal of Affective Disorders. 356. 664–671. 5 indexed citations

Sun, Ning, Jie Zhang, Jizhi Wang, et al.. (2022). Abnormal gut microbiota and bile acids in patients with first‐episode major depressive disorder and correlation analysis. Psychiatry and Clinical Neurosciences. 76(7). 321–328. 66 indexed citations

Lv, Xiaozhen, Rainer Leonhart, Hongjun Tian, et al.. (2021). Severe sleep disturbance is associated with executive function impairment in patients with first-episode, treatment-naïve major depressive disorders. BMC Psychiatry. 21(1). 198–198. 4 indexed citations

Lin, Jingyu, Yun‐Ai Su, Chuan Shi, et al.. (2021). Neurocognitive profiles of patients with first-episode and recurrent depression: a cross-sectional comparative study from China. Journal of Affective Disorders. 286. 110–116. 12 indexed citations

Mi, Weifeng, Fude Yang, Huafang Li, et al.. (2021). Efficacy, Safety, and Tolerability of Ansofaxine (LY03005) Extended-Release Tablet for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding, Phase 2 Clinical Trial. The International Journal of Neuropsychopharmacology. 25(3). 252–260. 16 indexed citations

Liu, Zhifen, Xinrong Li, Chen Chen, et al.. (2020). Identification of Antisense lncRNAs Targeting GSK3β as a Regulator in Major Depressive Disorder. Epigenomics. 12(19). 1725–1738. 4 indexed citations

Yang, Chunxia, Ai‐Xia Zhang, Ning Sun, et al.. (2018). Identify abnormalities in resting-state brain function between first-episode, drug-naive major depressive disorder and remitted individuals. Neuroreport. 29(11). 907–916. 22 indexed citations

Liu, Sha, Le Wang, Ning Sun, et al.. (2017). The gender-specific association of rs334558 in GSK3β with major depressive disorder. Medicine. 96(3). e5928–e5928. 14 indexed citations

10.

Sun, Ning, Lei Lei, Yanfang Wang, et al.. (2016). Preliminary comparison of plasma notch-associated microRNA-34b and -34c levels in drug naive, first episode depressed patients and healthy controls. Journal of Affective Disorders. 194. 109–114. 66 indexed citations

11.

Xie, Weiwei, Lehua Li, Gang Wang, et al.. (2014). Efficacy and Safety of Prolonged-Release Trazodone in Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Flexible-Dose Trial. Pharmacology. 94(5-6). 199–206. 14 indexed citations

12.

Li, Hui‐Jie, Xiaohua Cao, Xing-Ting Zhu, et al.. (2014). Surface-Based Regional Homogeneity in First-Episode, Drug-Naïve Major Depression: A Resting-State fMRI Study. BioMed Research International. 2014. 1–7. 28 indexed citations

13.

Liu, Zhifen, Hao Guo, Xiaohua Cao, et al.. (2014). A combined study of GSK3β polymorphisms and brain network topological metrics in major depressive disorder. Psychiatry Research Neuroimaging. 223(3). 210–217. 25 indexed citations

14.

Liu, Sha, Ning Sun, Yong Xu, et al.. (2012). Possible Association of the GSK3β Gene with the Anxiety Symptoms of Major Depressive Disorder and P300 Waveform. Genetic Testing and Molecular Biomarkers. 16(12). 1382–1389. 19 indexed citations

15.

Tian, Wenmin, Juan Zhang, Kerang Zhang, et al.. (2012). A study of the functional significance of epidermal growth factor in major depressive disorder. Psychiatric Genetics. 22(4). 161–167. 22 indexed citations

16.

Xu, Cheng, Xiaohua Cao, Qiang Gao, et al.. (2012). Effects of an antidepressant on neural correlates of emotional processing in patients with major depression. Neuroscience Letters. 527(1). 55–59. 18 indexed citations

17.

Chen, Yanbo, Kerang Zhang, Hong Yang, et al.. (2010). A cis-Phase Interaction Study of Genetic Variants Within the MAOA Gene in Major Depressive Disorder. Biological Psychiatry. 68(9). 795–800. 38 indexed citations

18.

Xu, Yong, Haiying Liu, Fei Li, et al.. (2010). A polymorphism in the microRNA-30e precursor associated with major depressive disorder risk and P300 waveform. Journal of Affective Disorders. 127(1-3). 332–336. 80 indexed citations

19.

Xu, Yong, Fei Li, Xuezhu Huang, et al.. (2009). The norepinephrine transporter gene modulates the relationship between urban/rural residency and major depressive disorder in a Chinese population. Psychiatry Research. 168(3). 213–217. 14 indexed citations

20.

Sun, Ning, Yong Xu, Yanfang Wang, et al.. (2008). The combined effect of norepinephrine transporter gene and negative life events in major depression of Chinese Han population. Journal of Neural Transmission. 115(12). 1681–1686. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact